More than three million cataract surgeries performed in Europe annually[1] Basel, Switzerland, June 16, 2015 - Alcon, the global leader in eye care and a division of Novartis, has received European CE ...

(RTTNews) - Alcon, a division of Novartis, announced it has received approval from the US FDA for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens with ACTIVEFOCUS optical design for ...

Novartis' ($NVS) Alcon received FDA approval for its implantable AcrySof IQ ReSTOR +2.5 Diopter intraocular lens (IOL), enabling vision correction at all distances in ...

Cataracts, an eye condition in which the lens becomes cloudy and impairs vision, affect more people than you might think. According to the nonprofit organization Prevent Blindness, over 25 million ...

The FDA's Ophthalmic Devices Advisory Committee panel overwhelmingly recommended PMA approval of Alcon's AcrySof IQ ReSTOR Multifocal Toric Intraocular Lens for patients undergoing cataract eye ...

GENEVA--(BUSINESS WIRE)-- Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon ® PanOptix ® Pro intraocular lens (IOL) ...

PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...

New Alcon Innovations in Intraocular Lenses, Digital Health Solutions to be Showcased at the AAO 2020 Virtual Annual Meeting Pivotal data on the novel AcrySof® IQ Vivity® IOL to be presented ahead of ...

To evaluate the postoperative outcomes of cataract eyes complicated with coexisting ocular pathologies that underwent implantation of a refractive multifocal intraocular lens (MIOL) with a ...

More than 25 million Americans are affected by cataracts,1 which cause dull, blurry vision and can have an emotional impact for many Cataracts, a cloudiness of the natural lens of the eye that can ...

When bilateral cataract surgery becomes necessary, many patients are faced with the alluring prospect of reducing or even eliminating the need to use spectacles for distance and near vision. Patients ...